Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRXN2 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | RPL7 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |
mRNA | ITGAL | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
mRNA | CD69 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
mRNA | FAM117A | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-09 |
mRNA | FHL3 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | CFAP161 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
mRNA | ZNF175 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | MLC1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | FAM78A | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-08 |